Biotech Values

[mcbio]

could you provide more info about this new path that TRGT is blazing for CNS trials?

LOL I was being entirely facetious in that post. TRGT presented promising Phase 2b data on their candidate for major depressive disorder in 2009 (#msg-42568910). However, most of the trial sites in that trial were in India. Notwithstanding the fact that TRGT was able to ink a nice deal with AZN as a result of this data, I still question how easily they'll be able to replicate these results in large Phase 3 trials in the U.S.